Aim of the present study was to evaluate whether polymorphisms in the p450  oxidoreductase (POR) gene may affect clinical features in patients with 21 hydroxylase deficiency. Here, POR is linked to classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency.